Jianmin Pharmaceutical Group Co Ltd Cash Flow Reinvestment Rate

Latest as of December 2025: 0.36x

Jianmin Pharmaceutical Group Co Ltd cash flow reinvestment rate. Jianmin Pharmaceutical Group Co Ltd (600976) has a Cash Flow Reinvestment Rate of 0.36x as of December 2025, reinvesting CN¥38.21 Million (capex CN¥23.23 Million plus investments CN¥-14.98 Million) from operating cash flow of CN¥106.82 Million. Explore Jianmin Pharmaceutical Group Co Ltd debt service capacity to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.36x
(Capex + Investments) / Operating CF

Total Reinvested

CN¥38.21 Million
Capex + Investments

Operating Cash Flow

CN¥106.82 Million
CNY

Capital Expenditures

CN¥23.23 Million
CNY

Cash Flow Reinvestment Rate of Jianmin Pharmaceutical Group Co Ltd (2003–2025)

Cash flow reinvestment rate of Jianmin Pharmaceutical Group Co Ltd from 2003 to 2025. Historical reinvestment intensity for Jianmin Pharmaceutical Group Co Ltd across 20 annual periods. Explore Jianmin Pharmaceutical Group Co Ltd capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.

Jianmin Pharmaceutical Group Co Ltd Cash Flow Reinvestment Rate by Year (2003–2025)

Jianmin Pharmaceutical Group Co Ltd cash flow reinvestment rate by year from 2003 to 2025. Year-by-year capital reinvestment analysis for Jianmin Pharmaceutical Group Co Ltd. For the full cash flow conversion analysis, see cash efficiency ratio of Jianmin Pharmaceutical Group Co Ltd.

Year Reinvestment Rate Total Reinvested (CNY) Operating CF Capex YoY Change
2025 0.42x CN¥114.34 Million CN¥274.53 Million CN¥100.67 Million ▼ -70.2%
2024 1.40x CN¥327.06 Million CN¥234.27 Million CN¥120.29 Million ▲ +164.2%
2023 0.53x CN¥141.81 Million CN¥268.39 Million CN¥64.50 Million ▼ -20.5%
2022 0.66x CN¥143.44 Million CN¥215.87 Million CN¥67.96 Million ▲ +45.5%
2021 0.46x CN¥118.37 Million CN¥259.18 Million CN¥55.99 Million ▼ -67.0%
2020 1.38x CN¥173.75 Million CN¥125.54 Million CN¥45.58 Million ▼ -28.2%
2019 1.93x CN¥143.57 Million CN¥74.45 Million CN¥69.31 Million ▼ -10.4%
2018 2.15x CN¥136.82 Million CN¥63.60 Million CN¥42.37 Million ▼ -62.3%
2017 5.71x CN¥200.93 Million CN¥35.20 Million CN¥41.93 Million ▲ +448.5%
2016 1.04x CN¥118.48 Million CN¥113.84 Million CN¥29.42 Million ▼ -51.3%
2015 2.14x CN¥103.55 Million CN¥48.45 Million CN¥29.75 Million ▲ +724.1%
2014 0.26x CN¥26.77 Million CN¥103.23 Million CN¥26.77 Million ▼ -50.8%
2013 0.53x CN¥23.90 Million CN¥45.36 Million CN¥23.90 Million ▲ +476.8%
2012 0.09x CN¥8.97 Million CN¥98.17 Million CN¥8.97 Million ▲ +153.3%
2010 0.04x CN¥5.41 Million CN¥150.08 Million CN¥5.41 Million ▼ -83.4%
2009 0.22x CN¥14.50 Million CN¥66.69 Million CN¥14.50 Million ▲ +175.5%
2008 0.08x CN¥8.69 Million CN¥110.11 Million CN¥8.69 Million ▼ -73.3%
2006 0.30x CN¥16.61 Million CN¥56.18 Million CN¥16.61 Million ▼ -97.9%
2004 13.95x CN¥57.64 Million CN¥4.13 Million CN¥57.64 Million ▼ -40.3%
2003 23.37x CN¥97.88 Million CN¥4.19 Million CN¥97.88 Million —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow